The Majority of Men with Lifelong Premature Ejaculation Prefer Daily Drug Treatment: An Observation Study in a Consecutive Group of Dutch Men
- 1 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 4 (4_Part_1) , 1028-1037
Abstract
Whether men with lifelong premature ejaculation (PE) prefer on-demand drug treatment to delay ejaculation time to daily drug treatment, has never been studied as a separate study question. To study how men with lifelong PE feel about the use of serotonergic antidepressants, and which option they would prefer for themselves: either a daily drug, a drug to be used on demand, or a topical anesthetic cream to be applied on demand. Treatment preference was determined by questionnaire. An observational questionnaire survey in a clinical sample. Preferences of different treatment strategies were queried before and after standard efficacy and safety information. A consecutive group of 88 men with lifelong PE who decided for themselves to be seen for rapid ejaculation was studied. The age was 37 ± 11 years (mean ± SD), range 18–64 years. None of these men was ever treated for PE and 21% used medication that did not affect sexual performance. Of them, 71 (81%) preferred a drug for daily use, 14 (16%) a drug on demand, while three men preferred topical anesthetic cream. Those men who initially preferred daily treatment did not change their view after standard information about efficacy and side effects, while 9 of 17 men who initially preferred on-demand drug treatment had switched their preferences to daily oral drug usage. Around 60% of men did not care about the nature of the drug, i.e., an antidepressant. The most frequently reported argument to prefer daily drug treatment was that this strategy would have the least effects toward the spontaneity of having sex. As opposed to agents that must be taken 4–6 hours prior to coitus and with the methods used here, this group of Dutch men with lifelong PE favor uninterrupted daily drug treatment to delay ejaculation mainly because daily treatment guarantees no interference with the spontaneity of having sex. Waldinger MD, Zwinderman AH, Olivier B, and Schweitzer DH. The majority of men with lifelong premature ejaculation prefer daily drug treatment: An observation study in a consecutive group of Dutch men.Keywords
This publication has 29 references indexed in Scilit:
- Premature EjaculationDrugs, 2007
- Oxytocin Involvement in SSRI-Induced Delayed Ejaculation: A Review of Animal StudiesThe Journal of Sexual Medicine, 2007
- On-Demand SSRI Treatment of Premature Ejaculation: Pharmacodynamic Limitations for Relevant Ejaculation Delay and Consequent SolutionsThe Journal of Sexual Medicine, 2005
- Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysisInternational Journal Of Impotence Research, 2004
- Management of premature ejaculation – a comparison of treatment outcome in patients with and without erectile dysfunctionInternational Journal of Andrology, 2002
- Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculationInternational Journal Of Impotence Research, 2001
- Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculationUrology, 1999
- Clomipramine in the treatment of rapid (premature) ejaculationJournal of Sex & Marital Therapy, 1999
- Clomipramine and Sexual Function in Men with Premature Ejaculation and ControlsJournal of Urology, 1996
- Clomipramine versus placebo in the treatment of premature ejaculation: A pilot studyJournal of Sex & Marital Therapy, 1993